{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T21:26:14Z","timestamp":1795209974059,"version":"4.10.3"},"reference-count":98,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"University of California Gene Medicine Program","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"name":"Jonsson Comprehensive Cancer Center at UCLA","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"name":"UCLA AIDS Institute","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13046-017-0535-z","type":"journal-article","created":{"date-parts":[[2017,5,5]],"date-time":"2017-05-05T10:25:34Z","timestamp":1493979934000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Overexpression of RKIP and its cross-talk with several regulatory gene products in multiple myeloma"],"prefix":"10.1186","volume":"36","author":[{"given":"Anna","family":"Shvartsur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin B.","family":"Givechian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hermes","family":"Garban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5594-2060","authenticated-orcid":false,"given":"Benjamin","family":"Bonavida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,5,5]]},"reference":[{"issue":"6","key":"535_CR1","doi-asserted-by":"publisher","first-page":"2962","DOI":"10.1182\/blood-2007-10-078022","volume":"111","author":"RA Kyle","year":"2008","unstructured":"Kyle RA, Rajkumar SV. Multiple myeloma. Blood. 2008;111(6):2962\u201372.","journal-title":"Blood"},{"issue":"4","key":"535_CR2","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1097\/MOH.0b013e328302c7f4","volume":"15","author":"ZW Li","year":"2008","unstructured":"Li ZW, Chen H, Campbell RA, Bonavida B, Berenson JR. NF-kappaB in the pathogenesis and treatment of multiple myeloma. Curr Opin Hematol. 2008;15(4):391\u20139.","journal-title":"Curr Opin Hematol"},{"issue":"12","key":"535_CR3","doi-asserted-by":"publisher","first-page":"4589","DOI":"10.1182\/blood-2005-10-4169","volume":"107","author":"M Dong","year":"2006","unstructured":"Dong M, Blobe GC. Role of transforming growth factor-beta in hematologic malignancies. Blood. 2006;107(12):4589\u201396.","journal-title":"Blood"},{"issue":"3","key":"535_CR4","first-page":"162","volume":"2","author":"R Feinman","year":"2004","unstructured":"Feinman R, Siegel DS, Berenson J. Regulation of NF-kB in multiple myeloma: therapeutic implications. Clin Adv Hematol Oncol. 2004;2(3):162\u20136.","journal-title":"Clin Adv Hematol Oncol"},{"issue":"2","key":"535_CR5","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/BF02983376","volume":"78","author":"H Ishikawa","year":"2003","unstructured":"Ishikawa H, Tsuyama N, Kawano MM. Interleukin-6-induced proliferation of human myeloma cells associated with CD45 molecules. Int J Hematol. 2003;78(2):95\u2013105.","journal-title":"Int J Hematol"},{"issue":"9","key":"535_CR6","doi-asserted-by":"publisher","first-page":"3511","DOI":"10.1182\/blood-2003-07-2254","volume":"103","author":"F Jundt","year":"2004","unstructured":"Jundt F, Probsting KS, Anagnostopoulos I, Muehlinghaus G, Chatterjee M, Mathas S, Bargou RC, Manz R, Stein H, Dorken B. Jagged1-induced Notch signaling drives proliferation of multiple myeloma cells. Blood. 2004;103(9):3511\u20135.","journal-title":"Blood"},{"issue":"9","key":"535_CR7","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.1182\/blood-2003-07-2340","volume":"103","author":"Y Nefedova","year":"2004","unstructured":"Nefedova Y, Cheng P, Alsina M, Dalton WS, Gabrilovich DI. Involvement of Notch-1 signaling in bone marrow stroma-mediated de novo drug resistance of myeloma and other malignant lymphoid cell lines. Blood. 2004;103(9):3503\u201310.","journal-title":"Blood"},{"issue":"20 Pt 2","key":"535_CR8","doi-asserted-by":"publisher","first-page":"6274s","DOI":"10.1158\/1078-0432.CCR-06-0648","volume":"12","author":"RN Pearse","year":"2006","unstructured":"Pearse RN. Wnt antagonism in multiple myeloma: a potential cause of uncoupled bone remodeling. Clin Cancer Res. 2006;12(20 Pt 2):6274s\u20138s.","journal-title":"Clin Cancer Res"},{"issue":"4","key":"535_CR9","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1365-2141.2005.05860.x","volume":"132","author":"H Yasui","year":"2006","unstructured":"Yasui H, Hideshima T, Richardson PG, Anderson KC. Novel therapeutic strategies targeting growth factor signalling cascades in multiple myeloma. Br J Haematol. 2006;132(4):385\u201397.","journal-title":"Br J Haematol"},{"issue":"13","key":"535_CR10","doi-asserted-by":"publisher","first-page":"3771","DOI":"10.1158\/1078-0432.CCR-06-2921","volume":"13","author":"H Younes","year":"2007","unstructured":"Younes H, Leleu X, Hatjiharissi E, Moreau AS, Hideshima T, Richardson P, Anderson KC, Ghobrial IM. Targeting the phosphatidylinositol 3-kinase pathway in multiple myeloma. Clin Cancer Res. 2007;13(13):3771\u20135.","journal-title":"Clin Cancer Res"},{"issue":"2","key":"535_CR11","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1615\/ForumImmunDisTher.v2.i1.110","volume":"2","author":"S Baritaki","year":"2011","unstructured":"Baritaki S, Huerta-Yepez S, Cabrava-Haimandez MD, Sensi M, Canevari S, Libra M, Penichet M, Chen H, Berenson JR, Bonavida B. Unique pattern of overexpression of Raf-1 kinase inhibitory protein in its inactivated phosphorylated form in human multiple myeloma. Forum Immunopathol Dis Therap. 2011;2(2):95\u2013105.","journal-title":"Forum Immunopathol Dis Therap"},{"key":"535_CR12","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.pharmthera.2015.01.011","volume":"150","author":"B Bonavida","year":"2015","unstructured":"Bonavida B, Kaufhold S. Prognostic significance of YY1 protein expression and mRNA levels by bioinformatics analysis in human cancers: a therapeutic target. Pharmacol Ther. 2015;150:149\u201368.","journal-title":"Pharmacol Ther"},{"issue":"6","key":"535_CR13","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1615\/CritRevOncog.2014011929","volume":"19","author":"B Bonavida","year":"2014","unstructured":"Bonavida B. RKIP-mediated chemo-immunosensitization of resistant cancer cells via disruption of the NF-kappaB\/Snail\/YY1\/RKIP resistance-driver loop. Crit Rev Oncog. 2014;19(6):431\u201345.","journal-title":"Crit Rev Oncog"},{"issue":"3\u20134","key":"535_CR14","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1615\/CritRevOncog.v16.i3-4.50","volume":"16","author":"B Bonavida","year":"2011","unstructured":"Bonavida B, Baritaki S. The novel role of Yin Yang 1 in the regulation of epithelial to mesenchymal transition in cancer via the dysregulated NF-kappaB\/Snail\/YY1\/RKIP\/PTEN Circuitry. Crit Rev Oncog. 2011;16(3\u20134):211\u201326.","journal-title":"Crit Rev Oncog"},{"issue":"4","key":"535_CR15","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.febslet.2009.12.051","volume":"584","author":"H Tang","year":"2010","unstructured":"Tang H, Park S, Sun SC, Trumbly R, Ren G, Tsung E, Yeung KC. RKIP inhibits NF-kappaB in cancer cells by regulating upstream signaling components of the IkappaB kinase complex. FEBS Lett. 2010;584(4):662\u20138.","journal-title":"FEBS Lett"},{"issue":"3\u20134","key":"535_CR16","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s10555-012-9365-9","volume":"31","author":"J Escara-Wilke","year":"2012","unstructured":"Escara-Wilke J, Yeung K, Keller ET. Raf kinase inhibitor protein (RKIP) in cancer. Cancer Metastasis Rev. 2012;31(3\u20134):615\u201320.","journal-title":"Cancer Metastasis Rev"},{"key":"535_CR17","doi-asserted-by":"publisher","first-page":"e185","DOI":"10.1038\/emm.2015.70","volume":"47","author":"AA Farooqi","year":"2015","unstructured":"Farooqi AA, Li Y, Sarkar FH. The biological complexity of RKIP signaling in human cancers. Exp Mol Med. 2015;47:e185.","journal-title":"Exp Mol Med"},{"issue":"6","key":"535_CR18","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/j.bcp.2004.04.024","volume":"68","author":"ET Keller","year":"2004","unstructured":"Keller ET, Fu Z, Brennan M. The role of Raf kinase inhibitor protein (RKIP) in health and disease. Biochem Pharmacol. 2004;68(6):1049\u201353.","journal-title":"Biochem Pharmacol"},{"issue":"6","key":"535_CR19","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1615\/CritRevOncog.2014011923","volume":"19","author":"K Lorenz","year":"2014","unstructured":"Lorenz K, Schmid E, Deiss K. RKIP: a governor of intracellular signaling. Crit Rev Oncog. 2014;19(6):489\u201396.","journal-title":"Crit Rev Oncog"},{"issue":"6","key":"535_CR20","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1615\/CritRevOncog.2014012000","volume":"19","author":"AE Yesilkanal","year":"2014","unstructured":"Yesilkanal AE, Rosner MR. Raf kinase inhibitory protein (RKIP) as a metastasis suppressor: regulation of signaling networks in cancer. Crit Rev Oncog. 2014;19(6):447\u201354.","journal-title":"Crit Rev Oncog"},{"issue":"4","key":"535_CR21","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/S0168-9525(99)01971-X","volume":"16","author":"SB Baylin","year":"2000","unstructured":"Baylin SB, Herman JG. DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet. 2000;16(4):168\u201374.","journal-title":"Trends Genet"},{"issue":"10","key":"535_CR22","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1136\/gut.2005.082859","volume":"55","author":"P Minoo","year":"2006","unstructured":"Minoo P, Baker K, Goswami R, Chong G, Foulkes WD, Ruszkiewicz AR, Barker M, Buchanan D, Young J, Jass JR. Extensive DNA methylation in normal colorectal mucosa in hyperplastic polyposis. Gut. 2006;55(10):1467\u201374.","journal-title":"Gut"},{"issue":"3","key":"535_CR23","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1002\/path.2879","volume":"225","author":"I Zlobec","year":"2011","unstructured":"Zlobec I, Bihl M, Foerster A, Rufle A, Lugli A. Comprehensive analysis of CpG island methylator phenotype (CIMP)-high, \u2212low, and -negative colorectal cancers based on protein marker expression and molecular features. J Pathol. 2011;225(3):336\u201343.","journal-title":"J Pathol"},{"issue":"15","key":"535_CR24","doi-asserted-by":"publisher","first-page":"13061","DOI":"10.1074\/jbc.M210015200","volume":"278","author":"KC Corbit","year":"2003","unstructured":"Corbit KC, Trakul N, Eves EM, Diaz B, Marshall M, Rosner MR. Activation of Raf-1 signaling by protein kinase C through a mechanism involving Raf kinase inhibitory protein. J Biol Chem. 2003;278(15):13061\u20138.","journal-title":"J Biol Chem"},{"key":"535_CR25","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1186\/1471-2407-13-463","volume":"13","author":"S Cross-Knorr","year":"2013","unstructured":"Cross-Knorr S, Lu S, Perez K, Guevara S, Brilliant K, Pisano C, Quesenberry PJ, Resnick MB, Chatterjee D. RKIP phosphorylation and STAT3 activation is inhibited by oxaliplatin and camptothecin and are associated with poor prognosis in stage II colon cancer patients. BMC Cancer. 2013;13:463.","journal-title":"BMC Cancer"},{"issue":"6966","key":"535_CR26","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1038\/nature02158","volume":"426","author":"K Lorenz","year":"2003","unstructured":"Lorenz K, Lohse MJ, Quitterer U. Protein kinase C switches the Raf kinase inhibitor from Raf-1 to GRK-2. Nature. 2003;426(6966):574\u20139.","journal-title":"Nature"},{"issue":"3","key":"535_CR27","doi-asserted-by":"publisher","first-page":"e92478","DOI":"10.1371\/journal.pone.0092478","volume":"9","author":"S Yousuf","year":"2014","unstructured":"Yousuf S, Duan M, Moen EL, Cross-Knorr S, Brilliant K, Bonavida B, LaValle T, Yeung KC, Al-Mulla F, Chin E, Chatterjee D. Raf kinase inhibitor protein (RKIP) blocks signal transducer and activator of transcription 3 (STAT3) activation in breast and prostate cancer. PLoS One. 2014;9(3):e92478.","journal-title":"PLoS One"},{"issue":"2","key":"535_CR28","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S0962-8924(00)01880-8","volume":"11","author":"RR Adams","year":"2001","unstructured":"Adams RR, Carmena M, Earnshaw WC. Chromosomal passengers and the (aurora) ABCs of mitosis. Trends Cell Biol. 2001;11(2):49\u201354.","journal-title":"Trends Cell Biol"},{"issue":"4","key":"535_CR29","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.molcel.2006.07.015","volume":"23","author":"EM Eves","year":"2006","unstructured":"Eves EM, Shapiro P, Naik K, Klein UR, Trakul N, Rosner MR. Raf kinase inhibitory protein regulates aurora B kinase and the spindle checkpoint. Mol Cell. 2006;23(4):561\u201374.","journal-title":"Mol Cell"},{"issue":"3","key":"535_CR30","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1039\/C0MB00208A","volume":"7","author":"F al-Mulla","year":"2011","unstructured":"al-Mulla F, Bitar MS, Taqi Z, Rath O, Kolch W. RAF kinase inhibitory protein (RKIP) modulates cell cycle kinetics and motility. Mol Biosyst. 2011;7(3):928\u201341.","journal-title":"Mol Biosyst"},{"issue":"21","key":"535_CR31","doi-asserted-by":"publisher","first-page":"3535","DOI":"10.1038\/sj.onc.1208435","volume":"24","author":"S Park","year":"2005","unstructured":"Park S, Yeung ML, Beach S, Shields JM, Yeung KC. RKIP downregulates B-Raf kinase activity in melanoma cancer cells. Oncogene. 2005;24(21):3535\u201340.","journal-title":"Oncogene"},{"issue":"9","key":"535_CR32","doi-asserted-by":"publisher","first-page":"3079","DOI":"10.1128\/MCB.20.9.3079-3085.2000","volume":"20","author":"K Yeung","year":"2000","unstructured":"Yeung K, Janosch P, McFerran B, Rose DW, Mischak H, Sedivy JM, Kolch W. Mechanism of suppression of the Raf\/MEK\/extracellular signal-regulated kinase pathway by the raf kinase inhibitor protein. Mol Cell Biol. 2000;20(9):3079\u201385.","journal-title":"Mol Cell Biol"},{"issue":"6749","key":"535_CR33","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/43686","volume":"401","author":"K Yeung","year":"1999","unstructured":"Yeung K, Seitz T, Li S, Janosch P, McFerran B, Kaiser C, Fee F, Katsanakis KD, Rose DW, Mischak H, Sedivy JM, Kolch W. Suppression of Raf-1 kinase activity and MAP kinase signalling by RKIP. Nature. 1999;401(6749):173\u20137.","journal-title":"Nature"},{"issue":"6","key":"535_CR34","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1615\/CritRevOncog.2014011950","volume":"19","author":"J Zhao","year":"2014","unstructured":"Zhao J, Wenzel S. Interactions of RKIP with inflammatory signaling pathways. Crit Rev Oncog. 2014;19(6):497\u2013504.","journal-title":"Crit Rev Oncog"},{"issue":"8","key":"535_CR35","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1002\/jcp.24335","volume":"228","author":"F Al-Mulla","year":"2013","unstructured":"Al-Mulla F, Bitar MS, Taqi Z, Yeung KC. RKIP: much more than Raf kinase inhibitory protein. J Cell Physiol. 2013;228(8):1688\u2013702.","journal-title":"J Cell Physiol"},{"issue":"36","key":"535_CR36","doi-asserted-by":"publisher","first-page":"5672","DOI":"10.1200\/JCO.2006.07.5499","volume":"24","author":"F Al-Mulla","year":"2006","unstructured":"Al-Mulla F, Hagan S, Behbehani AI, Bitar MS, George SS, Going JJ, Garcia JJ, Scott L, Fyfe N, Murray GI, Kolch W. Raf kinase inhibitor protein expression in a survival analysis of colorectal cancer patients. J Clin Oncol. 2006;24(36):5672\u20139.","journal-title":"J Clin Oncol"},{"issue":"3","key":"535_CR37","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1002\/pros.20319","volume":"66","author":"Z Fu","year":"2006","unstructured":"Fu Z, Kitagawa Y, Shen R, Shah R, Mehra R, Rhodes D, Keller PJ, Mizokami A, Dunn R, Chinnaiyan AM, Yao Z, Keller ET. Metastasis suppressor gene Raf kinase inhibitor protein (RKIP) is a novel prognostic marker in prostate cancer. Prostate. 2006;66(3):248\u201356.","journal-title":"Prostate"},{"issue":"12","key":"535_CR38","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1093\/jnci\/95.12.878","volume":"95","author":"Z Fu","year":"2003","unstructured":"Fu Z, Smith PC, Zhang L, Rubin MA, Dunn RL, Yao Z, Keller ET. Effects of raf kinase inhibitor protein expression on suppression of prostate cancer metastasis. J Natl Cancer Inst. 2003;95(12):878\u201389.","journal-title":"J Natl Cancer Inst"},{"issue":"20","key":"535_CR39","doi-asserted-by":"publisher","first-page":"7392","DOI":"10.1158\/1078-0432.CCR-05-0283","volume":"11","author":"S Hagan","year":"2005","unstructured":"Hagan S, Al-Mulla F, Mallon E, Oien K, Ferrier R, Gusterson B, Garcia JJ, Kolch W. Reduction of Raf-1 kinase inhibitor protein expression correlates with breast cancer metastasis. Clin Cancer Res. 2005;11(20):7392\u20137.","journal-title":"Clin Cancer Res"},{"issue":"15","key":"535_CR40","doi-asserted-by":"publisher","first-page":"5186","DOI":"10.1158\/0008-5472.CAN-03-3861","volume":"64","author":"MM Schuierer","year":"2004","unstructured":"Schuierer MM, Bataille F, Hagan S, Kolch W, Bosserhoff AK. Reduction in Raf kinase inhibitor protein expression is associated with increased Ras-extracellular signal-regulated kinase signaling in melanoma cell lines. Cancer Res. 2004;64(15):5186\u201392.","journal-title":"Cancer Res"},{"issue":"8","key":"535_CR41","doi-asserted-by":"publisher","first-page":"5441","DOI":"10.4049\/jimmunol.179.8.5441","volume":"179","author":"S Baritaki","year":"2007","unstructured":"Baritaki S, Katsman A, Chatterjee D, Yeung KC, Spandidos DA, Bonavida B. Regulation of tumor cell sensitivity to TRAIL-induced apoptosis by the metastatic suppressor Raf kinase inhibitor protein via Yin Yang 1 inhibition and death receptor 5 up-regulation. J Immunol. 2007;179(8):5441\u201353.","journal-title":"J Immunol"},{"issue":"17","key":"535_CR42","doi-asserted-by":"publisher","first-page":"17515","DOI":"10.1074\/jbc.M313816200","volume":"279","author":"D Chatterjee","year":"2004","unstructured":"Chatterjee D, Bai Y, Wang Z, Beach S, Mott S, Roy R, Braastad C, Sun Y, Mukhopadhyay A, Aggarwal BB, Darnowski J, Pantazis P, Wyche J, Fu Z, Kitagwa Y, Keller ET, Sedivy JM, Yeung KC. RKIP sensitizes prostate and breast cancer cells to drug-induced apoptosis. J Biol Chem. 2004;279(17):17515\u201323.","journal-title":"J Biol Chem"},{"issue":"4","key":"535_CR43","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1158\/0008-5472.CAN-10-3102","volume":"71","author":"F Al-Mulla","year":"2011","unstructured":"Al-Mulla F, Bitar MS, Al-Maghrebi M, Behbehani AI, Al-Ali W, Rath O, Doyle B, Tan KY, Pitt A, Kolch W. Raf kinase inhibitor protein RKIP enhances signaling by glycogen synthase kinase-3beta. Cancer Res. 2011;71(4):1334\u201343.","journal-title":"Cancer Res"},{"issue":"15","key":"535_CR44","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1038\/sj.onc.1210860","volume":"27","author":"S Beach","year":"2008","unstructured":"Beach S, Tang H, Park S, Dhillon AS, Keller ET, Kolch W, Yeung KC. Snail is a repressor of RKIP transcription in metastatic prostate cancer cells. Oncogene. 2008;27(15):2243\u20138.","journal-title":"Oncogene"},{"issue":"4","key":"535_CR45","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/emboj.2008.294","volume":"28","author":"S Dangi-Garimella","year":"2009","unstructured":"Dangi-Garimella S, Yun J, Eves EM, Newman M, Erkeland SJ, Hammond SM, Minn AJ, Rosner MR. Raf kinase inhibitory protein suppresses a metastasis signalling cascade involving LIN28 and let-7. EMBO J. 2009;28(4):347\u201358.","journal-title":"EMBO J"},{"issue":"2","key":"535_CR46","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.bbrc.2012.07.025","volume":"425","author":"L Huang","year":"2012","unstructured":"Huang L, Dai T, Lin X, Zhao X, Chen X, Wang C, Li X, Shen H, Wang X. MicroRNA-224 targets RKIP to control cell invasion and expression of metastasis genes in human breast cancer cells. Biochem Biophys Res Commun. 2012;425(2):127\u201333.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"535_CR47","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1002\/pmic.200800275","volume":"9","author":"B Schwanhausser","year":"2009","unstructured":"Schwanhausser B, Gossen M, Dittmar G, Selbach M. Global analysis of cellular protein translation by pulsed SILAC. Proteomics. 2009;9(1):205\u20139.","journal-title":"Proteomics"},{"issue":"7209","key":"535_CR48","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/nature07228","volume":"455","author":"M Selbach","year":"2008","unstructured":"Selbach M, Schwanhausser B, Thierfelder N, Fang Z, Khanin R, Rajewsky N. Widespread changes in protein synthesis induced by microRNAs. Nature. 2008;455(7209):58\u201363.","journal-title":"Nature"},{"issue":"21","key":"535_CR49","doi-asserted-by":"publisher","first-page":"8376","DOI":"10.1158\/0008-5472.CAN-09-1069","volume":"69","author":"S Baritaki","year":"2009","unstructured":"Baritaki S, Yeung K, Palladino M, Berenson J, Bonavida B. Pivotal roles of snail inhibition and RKIP induction by the proteasome inhibitor NPI-0052 in tumor cell chemoimmunosensitization. Cancer Res. 2009;69(21):8376\u201385.","journal-title":"Cancer Res"},{"issue":"2","key":"535_CR50","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.canlet.2010.08.012","volume":"299","author":"AB Beshir","year":"2010","unstructured":"Beshir AB, Ren G, Magpusao AN, Barone LM, Yeung KC, Fenteany G. Raf kinase inhibitor protein suppresses nuclear factor-kappaB-dependent cancer cell invasion through negative regulation of matrix metalloproteinase expression. Cancer Lett. 2010;299(2):137\u201349.","journal-title":"Cancer Lett"},{"issue":"4","key":"535_CR51","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1053\/j.gastro.2006.07.012","volume":"131","author":"HC Lee","year":"2006","unstructured":"Lee HC, Tian B, Sedivy JM, Wands JR, Kim M. Loss of Raf kinase inhibitor protein promotes cell proliferation and migration of human hepatoma cells. Gastroenterology. 2006;131(4):1208\u201317.","journal-title":"Gastroenterology"},{"issue":"4","key":"535_CR52","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1083\/jcb.145.4.837","volume":"145","author":"MA Sells","year":"1999","unstructured":"Sells MA, Boyd JT, Chernoff J. p21-activated kinase 1 (Pak1) regulates cell motility in mammalian fibroblasts. J Cell Biol. 1999;145(4):837\u201349.","journal-title":"J Cell Biol"},{"issue":"6","key":"535_CR53","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1134\/S0026893311060197","volume":"45","author":"H Xinzhou","year":"2011","unstructured":"Xinzhou H, Ning Y, Ou W, Xiaodan L, Fumin Y, Huitu L, Wei Z. RKIp inhibits the migration and invasion of human prostate cancer PC-3\u00a0M cells through regulation of extracellular matrix. Mol Biol (Mosk). 2011;45(6):1004\u201311.","journal-title":"Mol Biol (Mosk)"},{"key":"535_CR54","doi-asserted-by":"publisher","unstructured":"Bonavida B, Jazirehi A, Vega MI, Huerta-Yepez S, Baritaki S. Roles Each of Snail, Yin Yang 1 and RKIP in the Regulation of Tumor Cells Chemo-immuno-resistance to Apoptosis. For Immunopathol Dis and Therp, 2013;4(1):79-82. doi: 10.1615\/ForumImmunDisTher.2013008299 .","DOI":"10.1615\/ForumImmunDisTher.2013008299"},{"issue":"4","key":"535_CR55","first-page":"685","volume":"31","author":"JY Lee","year":"2007","unstructured":"Lee JY, Huerta-Yepez S, Vega M, Baritaki S, Spandidos DA, Bonavida B. The NO TRAIL to YES TRAIL in cancer therapy (review). Int J Oncol. 2007;31(4):685\u201391.","journal-title":"Int J Oncol"},{"issue":"4","key":"535_CR56","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s00428-013-1388-2","volume":"462","author":"J Afonso","year":"2013","unstructured":"Afonso J, Longatto-Filho A, Martinho O, Lobo F, Amaro T, Reis RM, Santos LL. Low RKIP expression associates with poor prognosis in bladder cancer patients. Virchows Arch. 2013;462(4):445\u201353.","journal-title":"Virchows Arch"},{"issue":"10","key":"535_CR57","doi-asserted-by":"publisher","first-page":"10095","DOI":"10.1007\/s13277-014-2303-4","volume":"35","author":"H Liu","year":"2014","unstructured":"Liu H, Li P, Li B, Sun P, Zhang J, Wang B, Jia B. RKIP suppresses gastric cancer cell proliferation and invasion and enhances apoptosis regulated by microRNA-224. Tumour Biol. 2014;35(10):10095\u2013103.","journal-title":"Tumour Biol"},{"issue":"5","key":"535_CR58","doi-asserted-by":"publisher","first-page":"4377","DOI":"10.1007\/s13277-013-1575-4","volume":"35","author":"Q Wang","year":"2014","unstructured":"Wang Q, Wu X, Wu T, Li GM, Shi Y. Clinical significance of RKIP mRNA expression in non-small cell lung cancer. Tumour Biol. 2014;35(5):4377\u201380.","journal-title":"Tumour Biol"},{"issue":"8","key":"535_CR59","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.acthis.2013.03.003","volume":"115","author":"V Cardile","year":"2013","unstructured":"Cardile V, Malaponte G, Loreto C, Libra M, Caggia S, Trovato FM, Musumeci G. Raf kinase inhibitor protein (RKIP) and phospho-RKIP expression in melanomas. Acta Histochem. 2013;115(8):795\u2013802.","journal-title":"Acta Histochem"},{"issue":"6","key":"535_CR60","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1615\/CritRevOncog.2014011987","volume":"19","author":"K Lamiman","year":"2014","unstructured":"Lamiman K, Keller JM, Mizokami A, Zhang J, Keller ET. Survey of Raf kinase inhibitor protein (RKIP) in multiple cancer types. Crit Rev Oncog. 2014;19(6):455\u201368.","journal-title":"Crit Rev Oncog"},{"issue":"11","key":"535_CR61","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1007\/s00018-013-1545-4","volume":"71","author":"C Gasparini","year":"2014","unstructured":"Gasparini C, Celeghini C, Monasta L, Zauli G. NF-kappaB pathways in hematological malignancies. Cell Mol Life Sci. 2014;71(11):2083\u2013102.","journal-title":"Cell Mol Life Sci"},{"issue":"18","key":"535_CR62","doi-asserted-by":"publisher","first-page":"3772","DOI":"10.1182\/blood-2010-02-270082","volume":"115","author":"T Hideshima","year":"2010","unstructured":"Hideshima T, Mitsiades C, Ikeda H, Chauhan D, Raje N, Gorgun G, Hideshima H, Munshi NC, Richardson PG, Carrasco DR, Anderson KC. A proto-oncogene BCL6 is up-regulated in the bone marrow microenvironment in multiple myeloma cells. Blood. 2010;115(18):3772\u20135.","journal-title":"Blood"},{"issue":"3","key":"535_CR63","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.clim.2006.03.015","volume":"120","author":"S Huerta-Yepez","year":"2006","unstructured":"Huerta-Yepez S, Vega M, Garban H, Bonavida B. Involvement of the TNF-alpha autocrine-paracrine loop, via NF-kappaB and YY1, in the regulation of tumor cell resistance to Fas-induced apoptosis. Clin Immunol. 2006;120(3):297\u2013309.","journal-title":"Clin Immunol"},{"issue":"1","key":"535_CR64","first-page":"39","volume":"27","author":"Y Kawano","year":"2012","unstructured":"Kawano Y, Ueno S, Abe M, Kikukawa Y, Yuki H, Iyama K, Okuno Y, Mitsuya H, Hata H. TRAIL produced from multiple myeloma cells is associated with osteolytic markers. Oncol Rep. 2012;27(1):39\u201344.","journal-title":"Oncol Rep"},{"issue":"17","key":"535_CR65","doi-asserted-by":"publisher","first-page":"6715","DOI":"10.1158\/0008-5472.CAN-10-1377","volume":"70","author":"SY Shin","year":"2010","unstructured":"Shin SY, Rath O, Zebisch A, Choo SM, Kolch W, Cho KH. Functional roles of multiple feedback loops in extracellular signal-regulated kinase and Wnt signaling pathways that regulate epithelial-mesenchymal transition. Cancer Res. 2010;70(17):6715\u201324.","journal-title":"Cancer Res"},{"issue":"7","key":"535_CR66","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1002\/gcc.20668","volume":"48","author":"L Agnelli","year":"2009","unstructured":"Agnelli L, Mosca L, Fabris S, Lionetti M, Andronache A, Kwee I, Todoerti K, Verdelli D, Battaglia C, Bertoni F, Deliliers GL, Neri A. A SNP microarray and FISH-based procedure to detect allelic imbalances in multiple myeloma: an integrated genomics approach reveals a wide gene dosage effect. Genes Chromosomes Cancer. 2009;48(7):603\u201314.","journal-title":"Genes Chromosomes Cancer"},{"issue":"5","key":"535_CR67","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1182\/blood.V99.5.1745","volume":"99","author":"F Zhan","year":"2002","unstructured":"Zhan F, Hardin J, Kordsmeier B, Bumm K, Zheng M, Tian E, Sanderson R, Yang Y, Wilson C, Zangari M, Anaissie E, Morris C, Muwalla F, van Rhee F, Fassas A, Crowley J, Tricot G, Barlogie B, Shaughnessy Jr J. Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cells. Blood. 2002;99(5):1745\u201357.","journal-title":"Blood"},{"issue":"4","key":"535_CR68","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1182\/blood-2006-07-037077","volume":"109","author":"F Zhan","year":"2007","unstructured":"Zhan F, Barlogie B, Arzoumanian V, Huang Y, Williams DR, Hollmig K, Pineda-Roman M, Tricot G, van Rhee F, Zangari M, Dhodapkar M, Shaughnessy Jr JD. Gene-expression signature of benign monoclonal gammopathy evident in multiple myeloma is linked to good prognosis. Blood. 2007;109(4):1692\u2013700.","journal-title":"Blood"},{"issue":"Database issue","key":"535_CR69","doi-asserted-by":"publisher","first-page":"D808","DOI":"10.1093\/nar\/gks1094","volume":"41","author":"A Franceschini","year":"2013","unstructured":"Franceschini A, Szklarczyk D, Frankild S, Kuhn M, Simonovic M, Roth A, Lin J, Minguez P, Bork P, von Mering C, Jensen LJ. STRING v9.1: protein-protein interaction networks, with increased coverage and integration. Nucleic Acids Res. 2013;41(Database issue):D808\u201315.","journal-title":"Nucleic Acids Res"},{"issue":"21","key":"535_CR70","doi-asserted-by":"publisher","first-page":"7207","DOI":"10.1128\/MCB.21.21.7207-7217.2001","volume":"21","author":"KC Yeung","year":"2001","unstructured":"Yeung KC, Rose DW, Dhillon AS, Yaros D, Gustafsson M, Chatterjee D, McFerran B, Wyche J, Kolch W, Sedivy JM. Raf kinase inhibitor protein interacts with NF-kappaB-inducing kinase and TAK1 and inhibits NF-kappaB activation. Mol Cell Biol. 2001;21(21):7207\u201317.","journal-title":"Mol Cell Biol"},{"issue":"11","key":"535_CR71","doi-asserted-by":"publisher","first-page":"4079","DOI":"10.1182\/blood.V99.11.4079","volume":"99","author":"N Mitsiades","year":"2002","unstructured":"Mitsiades N, Mitsiades CS, Poulaki V, Chauhan D, Richardson PG, Hideshima T, Munshi N, Treon SP, Anderson KC. Biologic sequelae of nuclear factor-kappaB blockade in multiple myeloma: therapeutic applications. Blood. 2002;99(11):4079\u201386.","journal-title":"Blood"},{"issue":"7","key":"535_CR72","doi-asserted-by":"publisher","first-page":"e66121","DOI":"10.1371\/journal.pone.0066121","volume":"8","author":"V Potluri","year":"2013","unstructured":"Potluri V, Noothi SK, Vallabhapurapu SD, Yoon SO, Driscoll JJ, Lawrie CH, Vallabhapurapu S. Transcriptional repression of Bim by a novel YY1-RelA complex is essential for the survival and growth of Multiple Myeloma. PLoS One. 2013;8(7):e66121.","journal-title":"PLoS One"},{"issue":"5","key":"535_CR73","doi-asserted-by":"publisher","first-page":"4987","DOI":"10.1007\/s13277-014-1659-9","volume":"35","author":"A Zaravinos","year":"2014","unstructured":"Zaravinos A, Kanellou P, Lambrou GI, Spandidos DA. Gene set enrichment analysis of the NF-kappaB\/Snail\/YY1\/RKIP circuitry in multiple myeloma. Tumour Biol. 2014;35(5):4987\u20135005.","journal-title":"Tumour Biol"},{"issue":"7","key":"535_CR74","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1182\/blood.V98.7.2183","volume":"98","author":"Q Chen","year":"2001","unstructured":"Chen Q, Gong B, Mahmoud-Ahmed AS, Zhou A, Hsi ED, Hussein M, Almasan A. Apo2L\/TRAIL and Bcl-2-related proteins regulate type I interferon-induced apoptosis in multiple myeloma. Blood. 2001;98(7):2183\u201392.","journal-title":"Blood"},{"issue":"37","key":"535_CR75","doi-asserted-by":"publisher","first-page":"5673","DOI":"10.1038\/sj.onc.1205664","volume":"21","author":"CS Mitsiades","year":"2002","unstructured":"Mitsiades CS, Mitsiades N, Poulaki V, Schlossman R, Akiyama M, Chauhan D, Hideshima T, Treon SP, Munshi NC, Richardson PG, Anderson KC. Activation of NF-kappaB and upregulation of intracellular anti-apoptotic proteins via the IGF-1\/Akt signaling in human multiple myeloma cells: therapeutic implications. Oncogene. 2002;21(37):5673\u201383.","journal-title":"Oncogene"},{"issue":"5","key":"535_CR76","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1182\/blood.V88.5.1805.1805","volume":"88","author":"Y Tu","year":"1996","unstructured":"Tu Y, Xu FH, Liu J, Vescio R, Berenson J, Fady C, Lichtenstein A. Upregulated expression of BCL-2 in multiple myeloma cells induced by exposure to doxorubicin, etoposide, and hydrogen peroxide. Blood. 1996;88(5):1805\u201312.","journal-title":"Blood"},{"issue":"3","key":"535_CR77","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.ccr.2007.08.011","volume":"12","author":"M Saito","year":"2007","unstructured":"Saito M, Gao J, Basso K, Kitagawa Y, Smith PM, Bhagat G, Pernis A, Pasqualucci L, Dalla-Favera R. A signaling pathway mediating downregulation of BCL6 in germinal center B cells is blocked by BCL6 gene alterations in B cell lymphoma. Cancer Cell. 2007;12(3):280\u201392.","journal-title":"Cancer Cell"},{"issue":"7","key":"535_CR78","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1038\/leu.2014.2","volume":"28","author":"V Ramakrishnan","year":"2014","unstructured":"Ramakrishnan V, Painuly U, Kimlinger T, Haug J, Rajkumar SV, Kumar S. Inhibitor of apoptosis proteins as therapeutic targets in multiple myeloma. Leukemia. 2014;28(7):1519\u201328.","journal-title":"Leukemia"},{"issue":"15","key":"535_CR79","doi-asserted-by":"publisher","first-page":"4041","DOI":"10.1182\/blood-2010-10-312793","volume":"117","author":"S Gardam","year":"2011","unstructured":"Gardam S, Turner VM, Anderton H, Limaye S, Basten A, Koentgen F, Vaux DL, Silke J, Brink R. Deletion of cIAP1 and cIAP2 in murine B lymphocytes constitutively activates cell survival pathways and inactivates the germinal center response. Blood. 2011;117(15):4041\u201351.","journal-title":"Blood"},{"issue":"33","key":"535_CR80","doi-asserted-by":"publisher","first-page":"11778","DOI":"10.1073\/pnas.0711122105","volume":"105","author":"DJ Mahoney","year":"2008","unstructured":"Mahoney DJ, Cheung HH, Mrad RL, Plenchette S, Simard C, Enwere E, Arora V, Mak TW, Lacasse EC, Waring J, Korneluk RG. Both cIAP1 and cIAP2 regulate TNFalpha-mediated NF-kappaB activation. Proc Natl Acad Sci U S A. 2008;105(33):11778\u201383.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"535_CR81","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1615\/CritRevImmunol.v29.i3.40","volume":"29","author":"K Wu","year":"2009","unstructured":"Wu K, Bonavida B. The activated NF-kappaB-Snail-RKIP circuitry in cancer regulates both the metastatic cascade and resistance to apoptosis by cytotoxic drugs. Crit Rev Immunol. 2009;29(3):241\u201354.","journal-title":"Crit Rev Immunol"},{"issue":"34","key":"535_CR82","doi-asserted-by":"publisher","first-page":"14246","DOI":"10.1073\/pnas.1018075108","volume":"108","author":"J Zhao","year":"2011","unstructured":"Zhao J, O'Donnell VB, Balzar S, Croix CMS, Trudeau JB, Wenzel SE. 15-Lipoxygenase 1 interacts with phosphatidylethanolamine-binding protein to regulate MAPK signaling in human airway epithelial cells. Proc Natl Acad Sci U S A. 2011;108(34):14246\u201351.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"535_CR83","first-page":"65","volume":"10","author":"M Jourdan","year":"1999","unstructured":"Jourdan M, Tarte K, Legouffe E, Brochier J, Rossi JF, Klein B. Tumor necrosis factor is a survival and proliferation factor for human myeloma cells. Eur Cytokine Netw. 1999;10(1):65\u201370.","journal-title":"Eur Cytokine Netw"},{"key":"535_CR84","doi-asserted-by":"publisher","first-page":"e194","DOI":"10.1038\/cddis.2011.78","volume":"2","author":"H Rauert","year":"2011","unstructured":"Rauert H, Stuhmer T, Bargou R, Wajant H, Siegmund D. TNFR1 and TNFR2 regulate the extrinsic apoptotic pathway in myeloma cells by multiple mechanisms. Cell Death Dis. 2011;2:e194.","journal-title":"Cell Death Dis"},{"issue":"5","key":"535_CR85","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1007\/s12032-014-0953-0","volume":"31","author":"MG Alexandrakis","year":"2014","unstructured":"Alexandrakis MG, Pappa CA, Kolovou A, Kyriakaki S, Vyzoukaki R, Devetzoglou M, Tsirakis G. Circulating levels of soluble Fas ligand reflect disease progression in multiple myeloma. Med Oncol. 2014;31(5):953.","journal-title":"Med Oncol"},{"issue":"5","key":"535_CR86","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/scrt322","volume":"4","author":"I Atsuta","year":"2013","unstructured":"Atsuta I, Liu S, Miura Y, Akiyama K, Chen C, An Y, Shi S, Chen FM. Mesenchymal stem cells inhibit multiple myeloma cells via the Fas\/Fas ligand pathway. Stem Cell Res Ther. 2013;4(5):111.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"535_CR87","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1182\/blood.V90.1.12","volume":"90","author":"A Villunger","year":"1997","unstructured":"Villunger A, Egle A, Marschitz I, Kos M, Bock G, Ludwig H, Geley S, Kofler R, Greil R. Constitutive expression of Fas (Apo-1\/CD95) ligand on multiple myeloma cells: a potential mechanism of tumor-induced suppression of immune surveillance. Blood. 1997;90(1):12\u201320.","journal-title":"Blood"},{"issue":"4","key":"535_CR88","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1182\/blood-2004-04-1322","volume":"106","author":"LY Dimberg","year":"2005","unstructured":"Dimberg LY, Dimberg AI, Ivarsson K, Stromberg T, Osterborg A, Nilsson K, Oberg F, Jernberg Wiklund H. Ectopic and IFN-induced expression of Fas overcomes resistance to Fas-mediated apoptosis in multiple myeloma cells. Blood. 2005;106(4):1346\u201354.","journal-title":"Blood"},{"issue":"14","key":"535_CR89","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.1016\/j.molimm.2010.05.003","volume":"47","author":"X Feng","year":"2010","unstructured":"Feng X, Yan J, Wang Y, Zierath JR, Nordenskjold M, Henter JI, Fadeel B, Zheng C. The proteasome inhibitor bortezomib disrupts tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression and natural killer (NK) cell killing of TRAIL receptor-positive multiple myeloma cells. Mol Immunol. 2010;47(14):2388\u201396.","journal-title":"Mol Immunol"},{"issue":"12","key":"535_CR90","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1111\/febs.13284","volume":"282","author":"Y Huang","year":"2015","unstructured":"Huang Y, Wang Y, Li X, Chen Z, Li X, Wang H, Ni M, Li J. Molecular mechanism of ER stress-induced gene expression of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in macrophages. FEBS J. 2015;282(12):2361\u201378.","journal-title":"FEBS J"},{"issue":"13","key":"535_CR91","doi-asserted-by":"publisher","first-page":"5404","DOI":"10.1128\/MCB.25.13.5404-5416.2005","volume":"25","author":"S Shetty","year":"2005","unstructured":"Shetty S, Graham BA, Brown JG, Hu X, Vegh-Yarema N, Harding G, Paul JT, Gibson SB. Transcription factor NF-kappaB differentially regulates death receptor 5 expression involving histone deacetylase 1. Mol Cell Biol. 2005;25(13):5404\u201316.","journal-title":"Mol Cell Biol"},{"issue":"3","key":"535_CR92","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1182\/blood.V98.3.795","volume":"98","author":"CS Mitsiades","year":"2001","unstructured":"Mitsiades CS, Treon SP, Mitsiades N, Shima Y, Richardson P, Schlossman R, Hideshima T, Anderson KC. TRAIL\/Apo2L ligand selectively induces apoptosis and overcomes drug resistance in multiple myeloma: therapeutic applications. Blood. 2001;98(3):795\u2013804.","journal-title":"Blood"},{"issue":"1","key":"535_CR93","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1615\/CritRevImmunol.v30.i1.20","volume":"30","author":"S Baritaki","year":"2010","unstructured":"Baritaki S, Bonavida B. Viral infection and cancer: the NF-kappaB\/Snail\/RKIP loop regulates target cell sensitivity to apoptosis by cytotoxic lymphocytes. Crit Rev Immunol. 2010;30(1):31\u201346.","journal-title":"Crit Rev Immunol"},{"key":"535_CR94","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4471-6458-6","volume-title":"Anticancer genes","author":"S Grimm","year":"2014","unstructured":"Grimm S. Anticancer genes. New York: Springer; 2014."},{"key":"535_CR95","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.semcdb.2015.01.012","volume":"39","author":"SP Cullen","year":"2015","unstructured":"Cullen SP, Martin SJ. Fas and TRAIL \u2018death receptors\u2019 as initiators of inflammation: implications for cancer. Semin Cell Dev Biol. 2015;39:26\u201334.","journal-title":"Semin Cell Dev Biol"},{"issue":"Database issue","key":"535_CR96","doi-asserted-by":"publisher","first-page":"D472","DOI":"10.1093\/nar\/gkt1102","volume":"42","author":"D Croft","year":"2014","unstructured":"Croft D, Mundo AF, Haw R, Milacic M, Weiser J, Wu G, Caudy M, Garapati P, Gillespie M, Kamdar MR, Jassal B, Jupe S, Matthews L, May B, Palatnik S, Rothfels K, Shamovsky V, Song H, Williams M, Birney E, Hermjakob H, Stein L, D'Eustachio P. The Reactome pathway knowledgebase. Nucleic Acids Res. 2014;42(Database issue):D472\u20137.","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"535_CR97","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.3390\/cancers4041180","volume":"4","author":"M Milacic","year":"2012","unstructured":"Milacic M, Haw R, Rothfels K, Wu G, Croft D, Hermjakob H, D'Eustachio P, Stein L. Annotating cancer variants and anti-cancer therapeutics in reactome. Cancers (Basel). 2012;4(4):1180\u2013211.","journal-title":"Cancers (Basel)"},{"issue":"7","key":"535_CR98","doi-asserted-by":"publisher","first-page":"5405","DOI":"10.1074\/jbc.M312044200","volume":"279","author":"HC Dan","year":"2004","unstructured":"Dan HC, Sun M, Kaneko S, Feldman RI, Nicosia SV, Wang HG, Tsang BK, Cheng JQ. Akt phosphorylation and stabilization of X-linked inhibitor of apoptosis protein (XIAP). J Biol Chem. 2004;279(7):5405\u201312.","journal-title":"J Biol Chem"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-017-0535-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T19:27:00Z","timestamp":1719170820000},"score":1,"resource":{"primary":{"URL":"http:\/\/jeccr.biomedcentral.com\/articles\/10.1186\/s13046-017-0535-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,5]]},"references-count":98,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["535"],"URL":"https:\/\/doi.org\/10.1186\/s13046-017-0535-z","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,5]]},"article-number":"62"}}